Cara Therapeutics

-$0.29 (-2.23%) Today
-$0.10 (-0.79%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CARA and other ETFs, options, and stocks.

About CARA

CARA Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). Its portfolio includes opioid-based products, anesthetic-based drugs, and analgesics that targets to alleviate itch and pain.

CEO
Derek T. Chalmers
Employees
80
Headquarters
Stamford, Connecticut
Founded
2004

CARA Key Statistics

Market Cap
636.14M
Price-Earnings Ratio
82.15
Dividend Yield
—
Average Volume
399.44K
High Today
$12.97
Low Today
$12.49
Open Price
$12.91
Volume
342.11K
52 Week High
$29.65
52 Week Low
$11.22

CARA Earnings

-$0.67
$0.08
$0.84
$1.59
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure